Definitive Healthcare (DH) Statistics

Definitive Healthcare Corp. (DH) is a leading provider of data and analytics for the healthcare industry. With their comprehensive database of healthcare providers, payers, and other organizations, they offer valuable insights and intelligence to their clients. As a result, DH has become an essential tool for healthcare organizations looking to gain a competitive edge in the market. DH provides a wide range of valuation metrics to help investors assess the financial health and performance of the company. These metrics include stock statistics such as the stock price, volume, and market capitalization, as well as fundamental metrics like revenue, earnings, and profitability. DH's stock performance is compared to the sector to evaluate its relative strength and weakness. This allows investors to determine whether DH is outperforming or underperforming its peers. DH's revenue per share is a key metric that indicates the amount of revenue generated by each outstanding share of the company's stock. This metric is often used to compare DH's revenue performance to other companies in the sector.

DH's enterprise to EBITDA ratio is a valuation metric that measures the company's overall profitability. It is calculated by dividing the enterprise value (market value of equity plus total debt) by the EBITDA (earnings before interest, taxes, depreciation, and amortization). A higher ratio indicates that DH's enterprise value is higher relative to its earnings, which may suggest that the company is overvalued. DH's profit margin is a key indicator of the company's financial health. It measures the percentage of revenue that is converted into profit. A higher profit margin indicates that DH is more efficient in generating profits from its revenue. DH's total debt is an important metric that reflects the company's financial leverage. It includes both short-term and long-term debt obligations. A high level of debt can increase DH's financial risk and reduce its ability to generate profits. DH's gross profit is the difference between its revenue and the cost of goods sold. It represents the amount of money left over after subtracting the cost of producing goods. DH's CEO is John C. Piecuch, who has been leading the company since its inception. As a seasoned healthcare executive, Piecuch brings a wealth of industry knowledge and experience to the table. Under his leadership, DH has experienced significant growth and expansion, solidifying its position as a leader in the healthcare data and analytics space.